GLAUPREXA - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 87379490
Serial Number
87379490
Word Mark
GLAUPREXA
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-01-04
Filing Date
2017-03-21
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-06-06
Law Office Assigned Location Code
L90
Employee Name
LATTUCA, FRANK J
Statements
Goods and Services
Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic and anti-inflammatory ointments; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-03-24
Primary Code
005
Correspondences
Name
Allergan, Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-03-24NEW APPLICATION ENTERED IN TRAM
2017-03-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-04-24ASSIGNED TO EXAMINER
2017-04-27APPROVED FOR PUB - PRINCIPAL REGISTER
2017-05-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-06-06PUBLISHED FOR OPPOSITION
2017-06-06OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-06-28EXTENSION OF TIME TO OPPOSE RECEIVED
2017-07-07TEAS POST PUBLICATION AMENDMENT RECEIVED
2017-07-12ASSIGNED TO PETITION STAFF
2017-07-15CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
2017-10-15EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
2017-11-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-04-30TEAS EXTENSION RECEIVED
2018-04-30EXTENSION 1 FILED
2018-04-30EXTENSION 1 GRANTED
2018-05-02NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-10-26TEAS EXTENSION RECEIVED
2018-10-26EXTENSION 2 FILED
2018-10-26EXTENSION 2 GRANTED
2018-10-30NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-03-12TEAS EXTENSION RECEIVED
2019-03-12EXTENSION 3 FILED
2019-03-12EXTENSION 3 GRANTED
2019-03-14NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-11-06TEAS EXTENSION RECEIVED
2019-11-06EXTENSION 4 FILED
2019-11-06EXTENSION 4 GRANTED
2019-11-08NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-13TEAS EXTENSION RECEIVED
2020-04-15CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-04-13EXTENSION 5 FILED
2020-04-15EXTENSION 5 GRANTED
2020-04-16NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-01-04ABANDONMENT - NO USE STATEMENT FILED
2021-01-04ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED